Skip to main content

Table 11 Performance of CD3+, TruScan Raman, and GPHF Minilab in distinguishing between different strengths

From: Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials

Brand name

Manufacturer

Sample composition/strength

Reference product

CD3+ (dosage)

TruScan raman

GPHF minilab

Winthrop

Sanofi

AS-AQ 50/135

AS-AQ, 100/270 mg, Sanofi

Faila

Passb

Fail

Winthrop

Sanofi

AS-AQ 100/270

AS-AQ, 50/135 mg, Sanofi

Fail

Pass

Fail

Lumerax

Ipca

AR-LU 40/240

AR-LU, 20/120 mg, Ipca

Fail

Pass

Fail

AR-LU 20/120

Ipca

AR-LU 20/120

AR-LU, 40/240 mg, Ipca

Fail

Pass

Fail

  1. AS-AQ Artesunate and Amodiaquine fixed-dose combination tablets
  2. AR-LU Artemether and Lumefantrine fixed dose combination tablets
  3. a Fail Sample is not consistent with reference product (different)
  4. b Pass Sample is consistent with reference product (identical)